Exhibit 1
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons and entities named below agree to the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the shares of common stock, par value $0.001 per share, of Forte Biosciences, Inc., a Delaware corporation, and further agree that this Joint Filing Agreement be included as Exhibit 1 to such Schedule 13D. In evidence thereof, the undersigned hereby execute this agreement this 4th day of August, 2021.
Dated: August 4, 2022
ATG FUND II LLC | ||
By: | ATG CAPITAL MANAGEMENT, LLC | |
Its: | Managing Member | |
By: | /s/ Gabriel Gliksberg | |
Name: | Gabriel Gliksberg | |
Title: | Managing Partner | |
ATG CAPITAL MANAGEMENT, LLC | ||
By: | /s/ Gabriel Gliksberg | |
Name: | Gabriel Gliksberg | |
Title: | Managing Partner |
/s/ Gabriel Gliksberg | |
Gabriel Gliksberg |